|
Delayed
Sao Paulo
19:21:25 18/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 86.64 BRL | -85.05% |
|
+1.69% | +10.74% |
| 08-12 | Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says | MT |
| 08-11 | Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $633 From $610, Maintains Buy Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.00% | -0.08% | +5.85% | +22.86% | +12.96% | +73.91% | +122.17% | +352.11% | +1,421.68% | 1,055B | |
| +2.97% | +3.98% | +8.57% | +18.01% | +30.54% | +53.27% | +56.61% | +52.46% | +123.78% | 632B | |
| +2.73% | +2.73% | +1.39% | +22.68% | +12.44% | +24.37% | +71.11% | +119.04% | +284.77% | 442B | |
| +1.35% | -2.17% | +8.80% | +12.19% | +9.96% | +40.98% | +41.50% | -3.13% | +48.27% | 351B | |
| +1.75% | -0.24% | +2.00% | +7.13% | +14.56% | +25.28% | +40.46% | +44.74% | +60.05% | 290B | |
| +2.13% | -0.32% | -4.64% | -13.89% | -14.39% | +0.58% | +10.77% | +35.20% | +133.97% | 243B | |
| +1.61% | +2.77% | +16.92% | +31.26% | +30.08% | +45.51% | +62.62% | +87.70% | +143.65% | 227B | |
| +1.35% | -3.53% | -9.65% | +3.62% | -8.89% | -14.72% | -52.63% | -11.46% | +91.50% | 200B | |
| +3.25% | +5.47% | +7.49% | +10.43% | +16.66% | +21.36% | +88.71% | +98.99% | +77.68% | 172B | |
| +1.54% | +2.42% | +10.16% | +7.64% | +9.50% | +8.76% | -25.63% | -44.71% | -22.52% | 153B | |
| +2.63% | +4.18% | +10.16% | +15.63% | +22.86% | +37.52% | +6.78% | -2.44% | +12.93% | 132B | |
| +2.63% | -0.16% | +10.06% | +21.13% | +16.64% | +35.64% | +53.36% | +171.51% | +433.62% | 131B | |
| +1.32% | +3.01% | +0.99% | +4.48% | -6.10% | -9.24% | -20.74% | -13.36% | +10.69% | 106B | |
| +1.97% | -0.42% | +0.32% | +0.61% | +3.48% | +31.20% | +39.96% | -1.01% | -9.80% | 101B | |
| -0.25% | -3.73% | -6.53% | -13.74% | -16.94% | +9.67% | +60.31% | +68.27% | +491.11% | 70.87B | |
| +3.43% | +2.15% | +4.05% | +8.05% | +17.93% | +29.33% | +28.45% | +56.18% | +21.58% | 55.24B | |
| +1.75% | -0.43% | +3.02% | +28.84% | +31.69% | +76.15% | -3.14% | +1.72% | -49.65% | 54.51B | |
| -0.95% | -3.34% | -1.54% | -3.00% | -12.09% | -17.40% | +29.09% | -4.35% | +214.56% | 51.66B | |
| +1.36% | +1.38% | +19.31% | +8.68% | +18.50% | +104.79% | +286.87% | +291.79% | -30.28% | 42.49B | |
| Average | +1.91% | -1.44% | +4.57% | +10.14% | +9.97% | +30.37% | +47.19% | +68.38% | +181.98% | 237.37B | |
| Weighted average by Cap. | +2.36% | -1.74% | +5.09% | +14.61% | +13.00% | +39.56% | +59.66% | +121.09% | +428.58% |
- Stock Market
- Stocks
- VRTX Stock
- VRTX34 Stock
- Sector Vertex Pharmaceuticals Incorporated
Select your edition
All financial news and data tailored to specific country editions
